Clinical radiology · 2019
Efficacy of model-based iterative reconstruction in cystic fibrosis assessment using CT.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin S, Lin M, Lau K K
Аннотация
AIM: To evaluate the efficacy of model-based iterative reconstruction (MBIR) constructed non-enhanced ultra-low dose (ULD) computed tomography (CT) of the chest to evaluate cystic fibrosis (CF) pathology.
MATERIALS AND METHODS: ULD-CT was compared with chest X-ray and standard adaptive statistical iterative reconstructed (ASIR) non-enhanced low-dose CT (LD-CT). The effective radiation dose was calculated from the recorded dose-length product (DLP) values and compared between the two CT methods. Identification of pathology was compared between ULD-CT and chest X-ray. It was hypothesised that ULD-CT would be superior to chest X-ray in the identification of CF pathology at lower doses than LD-CT.
RESULTS: The mean effective radiation dose of ULD-CT was 0.073 mSv, comparable to one chest X-ray, which was a 94% reduction compared to LD-CT. Compared to chest X-ray, ULD-CT detected on average, 2.3 more regions of bronchiectasis per study and better delineated varicose and cystic forms of bronchiectasis (p≤0.0001). ULD-CT identified four-times more mucous plugging than chest X-ray (p<0.000001) and twice the amount of consolidation (p=0.0002).
CONCLUSION: ULD-CT is superior to chest X-ray in quantifying CF disease and achieves remarkable radiation doses significantly lower than LD-CT, comparable to one chest radiograph. The present results suggest that MBIR-constructed ULD-CT is an effective imaging technique for CF surveillance, with potential applications in other disease settings.
MATERIALS AND METHODS: ULD-CT was compared with chest X-ray and standard adaptive statistical iterative reconstructed (ASIR) non-enhanced low-dose CT (LD-CT). The effective radiation dose was calculated from the recorded dose-length product (DLP) values and compared between the two CT methods. Identification of pathology was compared between ULD-CT and chest X-ray. It was hypothesised that ULD-CT would be superior to chest X-ray in the identification of CF pathology at lower doses than LD-CT.
RESULTS: The mean effective radiation dose of ULD-CT was 0.073 mSv, comparable to one chest X-ray, which was a 94% reduction compared to LD-CT. Compared to chest X-ray, ULD-CT detected on average, 2.3 more regions of bronchiectasis per study and better delineated varicose and cystic forms of bronchiectasis (p≤0.0001). ULD-CT identified four-times more mucous plugging than chest X-ray (p<0.000001) and twice the amount of consolidation (p=0.0002).
CONCLUSION: ULD-CT is superior to chest X-ray in quantifying CF disease and achieves remarkable radiation doses significantly lower than LD-CT, comparable to one chest radiograph. The present results suggest that MBIR-constructed ULD-CT is an effective imaging technique for CF surveillance, with potential applications in other disease settings.